Jean-Claude Sirard

Jean-Claude Sirard

Auto-generated profile, based on publicly available information

Jean-Claude Sirard

Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in Trends in Microbiology
Verified
Journal Article
Closed access
HRHugo Cruz Ramos
Hugo Cruz Ramos
MRMartin Rumbo
Martin Rumbo
JSJean-Claude Sirard
Jean-Claude Sirard

1 February 2006 in Immunity
Verified
Journal Article
Closed access
MBMarie Le Borgne
Marie Le Borgne
NENathalie Etchart
Nathalie Etchart
AGAnne Goubier
Anne Goubier
SLSergio A. Lira
Sergio A. Lira
JSJean Claude Sirard
Jean Claude Sirard
BDBertrand Dubois
Bertrand Dubois

28 January 2008 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ADArnaud Didierlaurent
Arnaud Didierlaurent
JGJohn Goulding
John Goulding
SPSeema Patel
Seema Patel
RSRobert Snelgrove
Robert Snelgrove
LLLionel Low
Lionel Low
THTracy Hussell
Tracy Hussell
The World Health Organization estimates that lower respiratory tract infections (excluding tuberculosis) account for ∼35% of all deaths caused by infectious diseases. In many cases, the cause of death may be caused by multiple pathogens, e.g., the life-threatening bacterial pneumonia observed in patients infected with influenza virus. The ability to evolve more efficient immunity on each successive encounter with antigen is the hallmark of the adaptive immune response. However, in the absence of cross-reactive T and B cell epitopes, one lung infection can modify immunity and pathology to the next for extended periods of time. We now report for the first time that this phenomenon is mediated by a sustained desensitization of lung sentinel cells to Toll-like receptor (TLR) ligands; this is an effect that lasts for several months after resolution of influenza or respiratory syncytial virus infection and is associated with reduced chemokine production and NF-κB activation in alveolar macrophages. Although such desensitization may be beneficial in alleviating overall immunopathology, the reduced neutrophil recruitment correlates with heightened bacterial load during secondary respiratory infection. Our data therefore suggests that post-viral desensitization to TLR signals may be one possible contributor to the common secondary bacterial pneumonia associated with pandemic and seasonal influenza infection.

9 September 2010 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
KEKathrin Endt
Kathrin Endt
BSBärbel Stecher
Bärbel Stecher
SCSamuel Chaffron
Samuel Chaffron
ESEmma Slack
Emma Slack
NTNicolas Tchitchek
Nicolas Tchitchek
WHWolf-Dietrich Hardt
Wolf-Dietrich Hardt
Many enteropathogenic bacteria target the mammalian gut. The mechanisms protecting the host from infection are poorly understood. We have studied the protective functions of secretory antibodies (sIgA) and the microbiota, using a mouse model for S. typhimurium diarrhea. This pathogen is a common cause of diarrhea in humans world-wide. S. typhimurium (S. tmatt, sseD) causes a self-limiting gut infection in streptomycin-treated mice. After 40 days, all animals had overcome the disease, developed a sIgA response, and most had cleared the pathogen from the gut lumen. sIgA limited pathogen access to the mucosal surface and protected from gut inflammation in challenge infections. This protection was O-antigen specific, as demonstrated with pathogens lacking the S. typhimurium O-antigen (wbaP, S. enteritidis) and sIgA-deficient mice (TCRβ−/−δ−/−, JH−/−, IgA−/−, pIgR−/−). Surprisingly, sIgA-deficiency did not affect the kinetics of pathogen clearance from the gut lumen. Instead, this was mediated by the microbiota. This was confirmed using ‘L-mice’ which harbor a low complexity gut flora, lack colonization resistance and develop a normal sIgA response, but fail to clear S. tmatt from the gut lumen. In these mice, pathogen clearance was achieved by transferring a normal complex microbiota. Thus, besides colonization resistance ( = pathogen blockage by an intact microbiota), the microbiota mediates a second, novel protective function, i.e. pathogen clearance. Here, the normal microbiota re-grows from a state of depletion and disturbed composition and gradually clears even very high pathogen loads from the gut lumen, a site inaccessible to most “classical” immune effector mechanisms. In conclusion, sIgA and microbiota serve complementary protective functions. The microbiota confers colonization resistance and mediates pathogen clearance in primary infections, while sIgA protects from disease if the host re-encounters the same pathogen. This has implications for curing S. typhimurium diarrhea and for preventing transmission. Numerous pathogens infect the gut. Protection against these infections is mediated by mucosal immune defenses including secreted IgA as well as by the competing intestinal microbiota. However, so far the relative importance of these two different defense mechanisms remains unclear. We addressed this question using the example of non-typhoidal Salmonella (NTS) gut infections which can be spread in stool of infected patients over long periods of time. We used a mouse model to reveal that the intestinal microbiota and the adaptive immune system hold different but complementary functions in fighting NTS infections. A primary Salmonella infection disrupts the normal microbiota and elicits Salmonella-specific sIgA. sIgA prevents disease when the animal is infected with NTS for a second time. However, sIgA was dispensable for pathogen clearance from the gut. Instead, this was mediated by the microbiota. By re-establishing its normal density and composition, the microbiota was necessary and sufficient for terminating long-term fecal Salmonella excretion. This establishes a novel paradigm: The microbiota clears the pathogen from the gut lumen, while sIgA protects from disease upon re-infection with the same pathogen. This has implications for the evolutionary role of sIgA responses as well as for developing microbiota-based therapies for curing infected patients.

20 November 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FSFrédéric Sierro
Frédéric Sierro
BDBertrand Dubois
Bertrand Dubois
ACAlix T Coste
Alix T Coste
DKDominique Kaiserlian
Dominique Kaiserlian
JKJean-Pierre Kraehenbuhl
Jean-Pierre Kraehenbuhl
JSJean-Claude Sirard
Jean-Claude Sirard
Enteropathogenic bacteria elicit mucosal innate and adaptive immune responses. We investigated whether gut epithelial cells played a role in triggering an adaptive immune response by recruiting dendritic cells (DCs). Immature DCs are selectively attracted by the CCL20 chemokine. The expression of theCCL20gene in human intestinal epithelial cell lines was up-regulated by pathogenic bacteria, includingSalmonellaspecies, but not by indigenous bacteria of the intestinal flora. TheSalmonellamachinery for epithelial cell invasion was not required forCCL20gene activation. Flagellin but not the lipopolysaccharide was found to be theSalmonellafactor responsible for stimulation of epithelial CCL20 production. CCL20 in turn triggered a specific migration of immature DCs. Our data show that crosstalk between bacterial flagellin and epithelial cells is essential for the recruitment of DCs, a mechanism that could be instrumental to initiate adaptive immune responses in the gut.

1 June 2004 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ADArnaud Didierlaurent
Arnaud Didierlaurent
IFIsabel Ferrero
Isabel Ferrero
LOLuc A Otten
Luc A Otten
BDBertrand Dubois
Bertrand Dubois
MRMonique Reinhardt
Monique Reinhardt
JSJean-Claude Sirard
Jean-Claude Sirard
Activation of dendritic cells (DC) by microbial products via Toll-like receptors (TLR) is instrumental in the induction of immunity. In particular, TLR signaling plays a major role in the instruction of Th1 responses. The development of Th2 responses has been proposed to be independent of the adapter molecule myeloid differentiation factor 88 (MyD88) involved in signal transduction by TLRs. In this study we show that flagellin, the bacterial stimulus for TLR5, drives MyD88-dependent Th2-type immunity in mice. Flagellin promotes the secretion of IL-4 and IL-13 by Ag-specific CD4+ T cells as well as IgG1 responses. The Th2-biased responses are associated with the maturation of DCs, which are shown to express TLR5. Flagellin-mediated DC activation requires MyD88 and induces NF-κB-dependent transcription and the production of low levels of proinflammatory cytokines. In addition, the flagellin-specific response is characterized by the lack of secretion of the Th1-promoting cytokine IL-12 p70. In conclusion, this study suggests that flagellin and, more generally, TLR ligands can control Th2 responses in a MyD88-dependent manner.